Ancora Advisors’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-234,620
Closed -$915K 1943
2024
Q1
$915K Buy
+234,620
New +$893K 0.02% 399
2022
Q3
Sell
-333
Closed -$2K 2246
2022
Q2
$2K Hold
333
﹤0.01% 1997
2022
Q1
$2K Hold
333
﹤0.01% 2174
2021
Q4
$2K Hold
333
﹤0.01% 2222
2021
Q3
$1K Hold
333
﹤0.01% 2140
2021
Q2
$3K Hold
333
﹤0.01% 1793
2021
Q1
$3K Hold
333
﹤0.01% 1615
2020
Q4
$1K Hold
333
﹤0.01% 1440
2020
Q3
$2K Hold
333
﹤0.01% 1333
2020
Q2
$2K Hold
333
﹤0.01% 1289
2020
Q1
$1K Hold
333
﹤0.01% 1404
2019
Q4
$3K Buy
+333
New +$1.99K ﹤0.01% 1309

Other funds holding ALIM

Ancora Advisors's ALIM Position: Q2 2024 in Review

Ancora Advisors sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 234,620 shares — an estimated $915K sold.

Ancora Advisors first reported a position in ALIM in Q4 2019 and held it in 12 quarters. The position peaked at $915K in Q1 2024. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

  • Ancora Advisors reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
  • Ancora Advisors sold 234,620 Alimera Sciences shares in Q2 2024, an estimated $915K.
  • Ancora Advisors first reported a position in Alimera Sciences in Q4 2019 and held it in 12 quarters.
  • Ancora Advisors's Alimera Sciences position peaked at $915K in Q1 2024.
  • 52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on Ancora Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.